動物用皮膚科治療薬の世界市場レポート 2025年

動物用皮膚科治療薬の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.5％で148億1,000万米ドルに成長します。予測期間における成長は、ペット保険導入の増加、アレルギー発症率の上昇、ペット用品の世界化、ホリスティックペットケアアプローチ、コンパニオンアニマル人口の増加、消費者教育に起因すると考えられます。予測期間の主な動向には、獣医皮膚科学調査の進歩、アレルギー管理への注力、局所治療への需要、栄養補助食品と皮膚科学的健康、獣医皮膚科学における遠隔医療、カスタマイズされた個別化治療、ペット保険、ヘルスケア支出が含まれます。

ペットの飼い主の増加は今後の動物用皮膚科治療薬市場を押し上げると予想されます。ペットの飼い主とは、動物を所有したり飼ったりする人たちのことで、ペットの健康と幸福に責任を持ち、必要な医療を提供します。例えば、オーストラリアに本部を置く非政府組織であるAnimal Medicines Australiaは、2022年にペットの所有者数が28,730.8に達し、2021年の39%から24%増加し、ペットの所有が大幅に増加したと報告しています。これは、オーストラリアの家庭におけるペットの人気の高まりを反映し、ペットの飼育とペットケアへの投資が力強い上昇傾向にあることを浮き彫りにしています。その結果、ペットの飼い主数の増加が動物用皮膚科治療薬市場を牽引しています。

皮膚科疾患の負担増は、動物用皮膚科治療薬市場の成長に大きく貢献すると予想されます。皮膚科疾患は、遺伝、環境要素、アレルギー、感染症、動物のライフスタイルの変化などの要因に影響され、皮膚に影響を及ぼす医学的状態の広範なスペクトルを包含します。飼い主は動物の健康の重要性を認識し、皮膚科的な問題に対して獣医師の治療を求めるようになってきています。さらに、動物と人間の間で感染しうる人獣共通感染症に対する認識が、動物の皮膚疾患の管理と治療の重要性を強調しています。一例として、2022年10月、英国放送協会の報告書は、インドで240万頭以上の動物にしこり皮膚病が影響を与え、11万頭以上の牛の死につながったことを強調しました。皮膚病負担の増加は、動物用皮膚科治療薬市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の動物用皮膚科治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の動物用皮膚科治療薬市場：成長率分析
• 世界の動物用皮膚科治療薬市場の実績：規模と成長, 2019-2024
• 世界の動物用皮膚科治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の動物用皮膚科治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の動物用皮膚科治療薬市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗真菌薬
• 抗菌薬
• 抗寄生虫薬
• 世界の動物用皮膚科治療薬市場：動物の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ペット
• 家畜
• 世界の動物用皮膚科治療薬市場：薬剤適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 寄生虫感染症
• アレルギー感染症
• その他の適応症
• 世界の動物用皮膚科治療薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外用
• 注射
• 経口
• 世界の動物用皮膚科治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小売り
• 病院薬局
• オンライン
• 世界の動物用皮膚科治療薬市場：抗真菌薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アゾール
• ポリエン
• アリルアミン
• エキノキャンディン
• 世界の動物用皮膚科治療薬市場：抗菌薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ベータラクタム
• テトラサイクリン
• マクロライド
• リンコサミド
• アミノグリコシド
• 世界の動物用皮膚科治療薬市場：抗寄生虫薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 殺虫剤
• 駆虫薬
• 局所治療
• 全身治療

第7章 地域別・国別分析

• 世界の動物用皮膚科治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の動物用皮膚科治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 動物用皮膚科治療薬市場：競合情勢
• 動物用皮膚科治療薬市場：企業プロファイル
  • Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Vetoquinol SA Overview, Products and Services, Strategy and Financial Analysis
  • Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Virbac S.A.
• Bimeda Inc.
• IDEXX Laboratories Inc.
• SavaVet
• Vetmedica
• Mars Incorporated
• Kindred Biosciences
• Bayer Animal Health
• Boehringer Ingelheim Vetmedica
• Dechra Pharmaceuticals PLC
• Norbrook Laboratories Limited
• Veterinary Centers of America Inc.
• Heska Corporation
• Biogenesis Bago
• Nexvet

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 動物用皮膚科治療薬市場2029：新たな機会を提供する国
• 動物用皮膚科治療薬市場2029：新たな機会を提供するセグメント
• 動物用皮膚科治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Veterinary dermatology drugs are medications specifically formulated to address skin conditions in animals, such as infections, allergies, and parasites. These treatments are utilized to relieve itching, reduce inflammation, and facilitate skin healing. By addressing dermatological issues, these drugs contribute to enhancing the overall health and comfort of affected animals.

The primary categories of veterinary dermatology drugs include antifungal drugs, antibacterial drugs, and antiparasitic drugs. Antifungals are pharmaceuticals that inhibit the growth of fungi responsible for infections commonly affecting the skin, hair, and nails of animals. These drugs are administered through various routes, including topical, injectable, and oral methods. The target recipients of these medications are diverse, ranging from companion animals to livestock. The drugs are utilized for indications such as parasitic infections and allergic reactions. Distribution channels for veterinary dermatology drugs encompass retail outlets, hospital pharmacies, and online platforms.

The veterinary dermatology drugs market research report is one of a series of new reports from The Business Research Company that provides veterinary dermatology drugs market statistics, including veterinary dermatology drugs industry global market size, regional shares, competitors with a veterinary dermatology drugs market share, detailed veterinary dermatology drugs market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary dermatology drugs industry. This veterinary dermatology drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary dermatology drugs market size has grown rapidly in recent years. It will grow from $8.6 billion in 2024 to $9.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to prevalence of dermatological conditions, increased veterinary spending, changing environmental factors, companion animal healthcare awareness, regulatory approvals, zoonotic disease awareness.

The veterinary dermatology drugs market size is expected to see rapid growth in the next few years. It will grow to $14.81 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to growing pet insurance adoption, rising incidence of allergies, globalization of pet products, holistic pet care approach, companion animal population growth, consumer education. Major trends in the forecast period include advancements in veterinary dermatology research, focus on allergy management, demand for topical treatments, nutraceuticals and dermatological health, telemedicine in veterinary dermatology, customized and personalized therapies, pet insurance and healthcare spending.

The growing number of pet owners is anticipated to boost the veterinary dermatology drugs market in the future. Pet owners are those who own or adopt animals and are responsible for their pets' health and well-being, providing necessary medical care, which in turn increases the demand for veterinary medications. For example, in 2022, Animal Medicines Australia, a non-governmental organization based in Australia, reported a significant rise in pet ownership, with the number of pet owners reaching 28,730.8, a 24% increase from 39% in 2021. This highlights a strong upward trend in pet adoption and investment in pet care, reflecting the growing popularity of pets in Australian homes. As a result, the increasing number of pet owners is driving the veterinary dermatology drugs market.

The rise in the burden of dermatological diseases is expected to contribute significantly to the growth of the veterinary dermatology drugs market. Dermatological diseases encompass a broad spectrum of medical conditions affecting the skin, influenced by factors such as genetics, environmental elements, allergies, infections, and lifestyle changes in animals. Owners, recognizing the importance of their animals' well-being, are increasingly seeking veterinary care for dermatological issues. Additionally, the awareness of zoonotic diseases, which can be transmitted between animals and humans, emphasizes the importance of managing and treating skin conditions in animals. As an example, in October 2022, a report from the British Broadcasting Corporation highlighted the impact of lumpy skin disease on over 2.4 million animals in India, leading to the death of more than 110,000 cattle. The rising burden of dermatological diseases is a significant factor driving the growth of the veterinary dermatology drugs market.

In the pursuit of sustaining their market position, major companies in the veterinary dermatology drugs market are innovating by introducing new enzyme-based healthcare solutions. For instance, in October 2022, Pet King Brands Inc., a US-based pet care company, expanded its ZYMOX Enzymatic Dermatology product line with three new offerings specifically designed for cats and kittens. These products, featuring feline-centric packaging and the Seal of Endorsement from The International Cat Association (TICA), aim to address ear and skin conditions in felines without the use of antibiotics or harsh ingredients. The ZYMOX for Cats and Kittens range includes Enzymatic Ear Solution with 0.5% Hydrocortisone, Enzymatic Ear Cleanser, and Enzymatic Topical Cream with 0.5% Hydrocortisone. Leveraging the patented LP3 Enzyme System, these products offer effective solutions for common feline conditions such as ear infections, irritated skin, hot spots, ringworm, and acne.

Major players in the veterinary dermatology drugs market are strategically forming partnerships to broaden their offerings. Strategic partnerships involve companies combining their strengths and resources to achieve mutual benefits and success. For example, in January 2022, Dechra, a UK-based specialist in veterinary pharmaceuticals and related products, entered into a partnership with Bioiberica, a life science company specializing in veterinary pharmaceuticals. The collaboration involves the licensing and distribution of the Atopivet line of dermatological products for cats and dogs in the US, aiming to enhance the health and wellbeing of humans, animals, and plants.

In January 2023, Animal Dermatology Group, Inc., a US-based veterinary dermatology firm, acquired Golden Gate Veterinary Specialists for an undisclosed sum. This acquisition is intended to enhance Animal Dermatology Group's ability to offer specialized veterinary services by integrating Golden Gate Veterinary Specialists. This move will expand their team of over 80 veterinary specialists and reinforce their commitment to providing high-quality, individualized care in dermatology, oncology, and internal medicine to meet the increasing demand for outpatient veterinary specialty services. Golden Gate Veterinary Specialists is a US-based practice specializing in dermatological and surgical care.

Major companies operating in the veterinary dermatology drugs market are Elanco Animal Health Inc., Merk & Co. Inc., Zoetis Inc., Vetoquinol SA, Ceva Sante Animale, Virbac S.A., Bimeda Inc., IDEXX Laboratories Inc. SavaVet, Vetmedica, Mars Incorporated, Kindred Biosciences, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Dechra Pharmaceuticals PLC, Norbrook Laboratories Limited, Veterinary Centers of America Inc., Heska Corporation, Biogenesis Bago, Nexvet, Aratana Therapeutics

North America was the largest region in the veterinary dermatology drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the veterinary dermatology drugs market report forecast period. The regions covered in the veterinary dermatology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary dermatology drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary dermatology drugs market consists of sales of dicloxacillin, erythromycin, tetracycline, and retinoids, which are naturally occurring and synthetic compounds with vitamin A activity. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Dermatology Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary dermatology drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary dermatology drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary dermatology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Antifungal Drugs; Antibacterial Drugs; Antiparasitic Drugs
• 2) By Animal Type: Companion Animal; Livestock Animal
• 3) By Drug Indication: Parasitic Infections; Allergic Infections; Other Indications
• 4) By Route Of Administration: Topical; Injectable; Oral
• 5) By Distribution Channel: Retail; Hospital Pharmacies; Online
• Subsegments:
• 1) By Antifungal Drugs: Azoles; Polyenes; Allylamines; Echinocandins
• 2) By Antibacterial Drugs: Beta-lactams; Tetracyclines; Macrolides; Lincosamides; Aminoglycosides
• 3) By Antiparasitic Drugs: Insecticides; Anthelmintics; Topical Treatments; Systemic Treatments
• Companies Mentioned: Elanco Animal Health Inc.; Merk & Co. Inc.; Zoetis Inc.; Vetoquinol SA; Ceva Sante Animale
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Dermatology Drugs Market Characteristics

3. Veterinary Dermatology Drugs Market Trends And Strategies

4. Veterinary Dermatology Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Dermatology Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Dermatology Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Dermatology Drugs Market Growth Rate Analysis
• 5.4. Global Veterinary Dermatology Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Dermatology Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Dermatology Drugs Total Addressable Market (TAM)

6. Veterinary Dermatology Drugs Market Segmentation

• 6.1. Global Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antifungal Drugs
• Antibacterial Drugs
• Antiparasitic Drugs
• 6.2. Global Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Companion Animal
• Livestock Animal
• 6.3. Global Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parasitic Infections
• Allergic Infections
• Other Indications
• 6.4. Global Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Injectable
• Oral
• 6.5. Global Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail
• Hospital Pharmacies
• Online
• 6.6. Global Veterinary Dermatology Drugs Market, Sub-Segmentation Of Antifungal Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Azoles
• Polyenes
• Allylamines
• Echinocandins
• 6.7. Global Veterinary Dermatology Drugs Market, Sub-Segmentation Of Antibacterial Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Beta-lactams
• Tetracyclines
• Macrolides
• Lincosamides
• Aminoglycosides
• 6.8. Global Veterinary Dermatology Drugs Market, Sub-Segmentation Of Antiparasitic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insecticides
• Anthelmintics
• Topical Treatments
• Systemic Treatments

7. Veterinary Dermatology Drugs Market Regional And Country Analysis

• 7.1. Global Veterinary Dermatology Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Dermatology Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Dermatology Drugs Market

• 8.1. Asia-Pacific Veterinary Dermatology Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Dermatology Drugs Market

• 9.1. China Veterinary Dermatology Drugs Market Overview
• 9.2. China Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Dermatology Drugs Market

• 10.1. India Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Dermatology Drugs Market

• 11.1. Japan Veterinary Dermatology Drugs Market Overview
• 11.2. Japan Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Dermatology Drugs Market

• 12.1. Australia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Dermatology Drugs Market

• 13.1. Indonesia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Dermatology Drugs Market

• 14.1. South Korea Veterinary Dermatology Drugs Market Overview
• 14.2. South Korea Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Dermatology Drugs Market

• 15.1. Western Europe Veterinary Dermatology Drugs Market Overview
• 15.2. Western Europe Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Dermatology Drugs Market

• 16.1. UK Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Dermatology Drugs Market

• 17.1. Germany Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Dermatology Drugs Market

• 18.1. France Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Dermatology Drugs Market

• 19.1. Italy Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Dermatology Drugs Market

• 20.1. Spain Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Dermatology Drugs Market

• 21.1. Eastern Europe Veterinary Dermatology Drugs Market Overview
• 21.2. Eastern Europe Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Dermatology Drugs Market

• 22.1. Russia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Dermatology Drugs Market

• 23.1. North America Veterinary Dermatology Drugs Market Overview
• 23.2. North America Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Dermatology Drugs Market

• 24.1. USA Veterinary Dermatology Drugs Market Overview
• 24.2. USA Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Dermatology Drugs Market

• 25.1. Canada Veterinary Dermatology Drugs Market Overview
• 25.2. Canada Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Dermatology Drugs Market

• 26.1. South America Veterinary Dermatology Drugs Market Overview
• 26.2. South America Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Dermatology Drugs Market

• 27.1. Brazil Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Dermatology Drugs Market

• 28.1. Middle East Veterinary Dermatology Drugs Market Overview
• 28.2. Middle East Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Dermatology Drugs Market

• 29.1. Africa Veterinary Dermatology Drugs Market Overview
• 29.2. Africa Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Dermatology Drugs Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Dermatology Drugs Market Competitive Landscape
• 30.2. Veterinary Dermatology Drugs Market Company Profiles
  • 30.2.1. Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Vetoquinol SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Dermatology Drugs Market Other Major And Innovative Companies

• 31.1. Virbac S.A.
• 31.2. Bimeda Inc.
• 31.3. IDEXX Laboratories Inc.
• 31.4. SavaVet
• 31.5. Vetmedica
• 31.6. Mars Incorporated
• 31.7. Kindred Biosciences
• 31.8. Bayer Animal Health
• 31.9. Boehringer Ingelheim Vetmedica
• 31.10. Dechra Pharmaceuticals PLC
• 31.11. Norbrook Laboratories Limited
• 31.12. Veterinary Centers of America Inc.
• 31.13. Heska Corporation
• 31.14. Biogenesis Bago
• 31.15. Nexvet

32. Global Veterinary Dermatology Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Dermatology Drugs Market

34. Recent Developments In The Veterinary Dermatology Drugs Market

35. Veterinary Dermatology Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Dermatology Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Dermatology Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Dermatology Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer